Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey
Familial Cancer · 24.07.2026 · 25 (3)
DOI: 10.1007/s10689-026-00596-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Familial Cancer, online erschienen am 24.07.2026. Verfasst von Luigi Cerbone und 10 weiteren Autor:innen. Beteiligte Einrichtung: SSD Mesotelioma, Melanoma E Tumori Rari, AOU SS Antonio E Biagio E Cesare Arrigo Alessandria, Alessandria, Italy. Hauptthemen laut MEDLINE: Genetic Testing, Mesothelioma, Pleural Neoplasms, Attitude of Health Personnel. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi del Piemonte Orientale Amedeo Avogrado.
Abstract (Originalsprache)
Pleural mesothelioma (PM) is a malignancy with a relevant genetic component, with germline mutations identified in up to 12% of cases. International guidelines recommend universal germline testing; however, its implementation in routine clinical practice remains inconsistent. This nationwide survey aimed to assess current clinical practice, attitudes, and barriers related to genetic testing among Italian specialists within the Mesothelioma Team Italy (MET-I) network. A 24-item questionnaire was distributed to MET-I members in 2025, exploring access to testing, clinical use, and perceived obstacles to both germline and somatic DNA sequencing. Forty-five physicians responded (53.6%). Although access to germline testing was relatively high (77.8%), only 6.7% of respondents routinely recommended it. Conversely, somatic NGS was widely available (95.6%) and primarily used for clinical trial screening (66.7%). The main barriers to germline testing included costs (62.2%), limited access to genetic counseling (51.1%), and insufficient physician awareness (48.8%). Despite the availability of genetic testing technologies, germline genetic testing in PM is underutilized in Italy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SSD Mesotelioma, Melanoma E Tumori Rari, AOU SS Antonio E Biagio E Cesare Arrigo Alessandria, Alessandria, Italy.
- Department for Sustainable Development and Ecological Transition, Università del Piemonte Orientale, Vercelli, Italy.
- Medical Oncology Department, IRCCS Humanitas Research Hospital, Milan, Italy.
- Medical Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
- Medical Oncology 2, Istituto Oncologico Veneto, Padua, Italy.
- Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
Förderung
- Università degli Studi del Piemonte Orientale Amedeo Avogrado
Zitieren
APA
Cerbone, L., Perrino, M., Grosso, F., Ganzinelli, M., Lo Russo, G., Pasello, G., Zucali, P. A., Ceresoli, G. L., Occhipinti, M., Sculco, M., & on the behalf of MET-I (Mesothelioma team Italy) (2026). Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey. Familial Cancer, 25(3). https://doi.org/10.1007/s10689-026-00596-7
Vancouver
Cerbone L, Perrino M, Grosso F, Ganzinelli M, Lo Russo G, Pasello G, et al. Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey. Familial Cancer. 2026;25(3). doi:10.1007/s10689-026-00596-7
BibTeX
@article{Cerbone2026,
author = {Cerbone, Luigi and Perrino, Matteo and Grosso, Federica and Ganzinelli, Monica and Lo Russo, Giuseppe and Pasello, Giulia and Zucali, Paolo Andrea and Ceresoli, Giovanni Luca and Occhipinti, Mario and Sculco, Marika and on the behalf of MET-I (Mesothelioma team Italy), on the behalf of MET-I (Mesothelioma team Italy)},
title = {Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey},
journal = {Familial Cancer},
year = {2026},
volume = {25},
number = {3},
doi = {10.1007/s10689-026-00596-7}
}
EUVIMED